Abstract
Respiratory failure (RF) is a frequent occurrence in critically ill patients and is associated with significant morbidity and mortality as well as resource use. To improve the monitoring and management of RF in intensive care unit (ICU) patients, we used machine learning to develop a monitoring system covering the entire management cycle of RF, from early detection and monitoring, to assessment of readiness for extubation and prediction of extubation failure risk. For patients in the ICU in the study cohort, the system predicts 80% of RF events at a precision of 45% with 65% identified 10h before the onset of an RF event. This significantly improves upon a standard clinical baseline based on the SpO2/FiO2 ratio. After a careful analysis of ICU differences, the RF alarm system was externally validated showing similar performance for patients in the external validation cohort. Our system also provides a risk score for extubation failure for patients who are clinically ready to extubate, and we illustrate how such a risk score could be used to extubate patients earlier in certain scenarios. Moreover, we demonstrate that our system, which closely monitors respiratory failure, ventilation need, and extubation readiness for individual patients can also be used for ICU-level ventilator resource planning. In particular, we predict ventilator use 8-16h into the future, corresponding to the next ICU shift, with a mean absolute error of 0.4 ventilators per 10 patients effective ICU capacity.
Competing Interest Statement
S.L.H. is a board member of the not-for-profit Association for Health, Learning, and Inference (AHLI). G.R. is cofounder and member of the scientific board of Computomics GmbH.
Funding Statement
This project was supported by the Grant No. 205321_176005 of the Swiss National Science Foundation (to T.M.M. and G.R.), and grant #2022-278 of the Strategic Focus Area Personalized Health and Related Technologies (PHRT) of the ETH Domain (Swiss Federal Institutes of Technology), and ETH core funding (to G.R.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The institutional review board (IRB) of the Canton of Bern approved the study (BASEC 2016 01463). The need for obtaining informed patient consent for patient data from our institution was waived owing to the retrospective and observational nature of the study. No IRB approval is required for the anonymous public external validation data-set from Amsterdam University Medical Center.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data used in this study were obtained from University Hospital Bern and we aim to make it available on physionet.org in anonymized form, similar to the HIRID-I dataset associated with a previous study (Hyland et al., Nature Medicine, 2020).
